PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma
- PMID: 36072622
- PMCID: PMC9398827
- DOI: 10.1155/2022/6057017
PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma
Abstract
The aim of this study was to investigate the clinical value of positron emission tomography/computerized tomography scanning (PET/CT) in the evaluation of the effect of allogeneic hematopoietic stem cell transplantation in the treatment of T lymphoblastic lymphoma. 12 relevant research articles were collected through layer-by-layer screening in large databases such as Pubmed, Baidu Scholar, and China How Net, and analyzed and summarized using indicators such as progression-free survival (PFS), overall survival (OS), hazard ratio (HR), maximum standardized uptake value (SUV max), total metabolic tumor volume (TMTV), total lesion glycolysis (TLG), elevated lactate dehydrogenase (LDH), and β2-microglobulin (β2-MG). The results showed that before treatment, 18F-FDG PET/CT baseline diagnosis could accurately stage the patients; during treatment, 18F-FDG PET/CT detection could provide effective treatment information; and after treatment, complications were found during 18F-FDG PET/CT detection. In summary, 18F-FDG PET/CT can monitor and evaluate treatment prognosis at baseline, middle, and late stages, and 18F-FDG PET/CT has become an indispensable and important examination technique in clinical work.
Copyright © 2022 Jin Zhao et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211056478. doi: 10.1177/15330338211056478. Technol Cancer Res Treat. 2021. PMID: 34806464 Free PMC article.
-
[Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].Zhonghua Zhong Liu Za Zhi. 2019 Nov 23;41(11):831-836. doi: 10.3760/cma.j.issn.0253-3766.2019.11.006. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31770850 Chinese.
-
Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation.Clin Transl Oncol. 2021 Aug;23(8):1571-1576. doi: 10.1007/s12094-021-02551-7. Epub 2021 Jan 15. Clin Transl Oncol. 2021. PMID: 33449269
-
Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with 18F-FDG PET/CT, in patients with diffuse large cell B-cell lymphoma.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):340-346. doi: 10.1016/j.remn.2020.06.007. Epub 2020 Jul 6. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32646783 English, Spanish.
-
Total tumor burden in lymphoma - an evolving strong prognostic parameter.Br J Radiol. 2021 Nov 1;94(1127):20210448. doi: 10.1259/bjr.20210448. Epub 2021 Aug 11. Br J Radiol. 2021. PMID: 34379496 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources